Abivax

About:

Abivax develops medicines that alter the body's natural immune system mechanisms.

Website: http://www.abivax.com

Twitter/X: abivax_

Top Investors: Deerfield, Invus, Sofinnova Partners, Deep Track Capital, Samsara BioCapital

Description:

Abivax is a clinical-stage biotechnology company, that mobilizes the body’s natural immune machinery to treat patients with autoimmune diseases, viral infections, and cancer. Their aim is to use Abivax's drug development platforms to provide novel and effective treatments to patients with large unmet needs in these therapeutic areas.